-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IVS+uGU/Vb4O2j+6LRDwp+Jc6s+3lf2dvcAtlDj5on99d1MuZ8yhYtjuN+DlHN3H 3XkIIQeU1Imzzj9Dqd3JBw== 0001209191-05-035682.txt : 20050706 0001209191-05-035682.hdr.sgml : 20050706 20050706162201 ACCESSION NUMBER: 0001209191-05-035682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050701 FILED AS OF DATE: 20050706 DATE AS OF CHANGE: 20050706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 MAIL ADDRESS: STREET 1: 6611 TRIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHINNICI JOSEPH R CENTRAL INDEX KEY: 0001177263 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05941004 BUSINESS ADDRESS: STREET 1: 1201 WINTERSON ROAD CITY: LINTHICUM STATE: MD ZIP: 21090 BUSINESS PHONE: 4108658500 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-07-01 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001177263 CHINNICI JOSEPH R C/O GUILFORD PHARMACEUTICALS 6611 TRIBUTARY ST. BALTIMORE MD 21224 1 0 0 0 Restricted Stock Units 0.00 2005-07-01 4 A 0 5727 2.27 A Common Stock 5727 10748 D Stock Options (Right to buy) 2.47 2006-05-04 2015-05-04 Common Stock 7500 7500 D Stock Options (Right to buy) 2.94 2003-02-18 2012-02-18 Common Stock 30000 30000 D Stock Options (Right to buy) 6.38 2005-05-05 2014-05-05 Common Stock 7500 7500 D Consists of Restricted Stock Units granted under the Company's 2002 Stock Award and Incentive Plan in lieu of cash payment for board retainer and board committee fees, which Restricted Stock Units are 100% vested as of the date of the grant. The Restricted Stock Units will be exchanged for shares of the Company's common stock six months after termination of Mr. Chinnici's service with the Company's Board of Directors. Asher M. Rubin, Attorney-in-fact 2005-07-06 -----END PRIVACY-ENHANCED MESSAGE-----